[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]               
[Page 392]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-84]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 4, 2004, Noramco 
Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by 
letter to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of Dihydrocodeine (9120), a basic class of 
controlled substance listed in Schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than (60 
days from publication).

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-52 Filed 1-3-05; 8:45 am]

BILLING CODE 4410-09-P